Internal Medicine Meeting Recordings
Internal medicine physicians are often on the “front lines” in both specialty and primary care settings for the assessment and treatment of psychiatric disorders. Most psychiatric disorders are treated by nonbehavioral specialists, and more than 80% of antidepressants are prescribed by non-psychiatrists. Formal psychiatric training for internists is often limited and does not cover foundational topics, which are relevant to everyday practice in the general medical setting. This Pre-Course, recorded in conjunction with the Internal Medicine Meeting 2023, provides a practical, evidence-based update for internists on approaches to interviewing patients with the goal of recognizing, diagnosing, treating, and/or referring patients with mental health disorders. Expert clinician-educators with training in both internal medicine and psychiatry emphasize the importance of a patient-centered approach, motivational interviewing, and basic cognitive behavioral techniques that can be quickly used in medical settings. An overview on psychopharmacology strategies in the general medical setting is also discussed. Faculty focus on psychiatric diagnoses that are prevalent in medical practice, including major depressive disorder, anxiety disorders, trauma-related disorders, and bipolar mood disorders, with a goal of improving recognition, confidence in management, and effectiveness of referral.
CME/MOC:
Up to 7
AMA PRA Category 1 Credits ™ and MOC Points
Expires June 06, 2026
active
Cost:
Discounted to Members
Format:
Video Recordings
Product:
Internal Medicine Meeting Recordings
ACP's Internal Medicine Meeting Recording packages include video and slide presentations from a curated selection of popular and highly rated sessions delivered during or derived from the ACP Internal Medicine Meeting. Trusted, timely content in general internal medicine and the subspecialties is presented by expert faculty; CME and MOC available.
The following individual(s) disclosed relevant financial relationships with ACCME-defined ineligible companies. No other individuals in control of content have anything to disclose. All relevant financial relationships have been mitigated.
Jeffrey Rado, MD
Research Grants/Contracts: Alkermes, Inc., Roche, Biogen, Inc.
Honoraria: Alkermes, Inc.
Consultantship: Otsuka America Pharmaceutical, Inc.
Independent Contractor – Data & Safety Monitoring: Boehringer Ingelheim Pharmaceuticals, Inc.
The ܼˮ̳ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The ܼˮ̳ designates this enduring material for a maximum of 7 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Release Date: June 7, 2023
End Date: June 6, 2026